EMD-30325

Single-particle
3.52 Å
EMD-30325 Deposition: 08/06/2020
Map released: 16/12/2020
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-30325

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7cab summary report (pdf.gz) Map-7cab FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody

EMD-30325

Single-particle
3.52 Å
EMD-30325 Deposition: 08/06/2020
Map released: 16/12/2020
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 spike glycoprotein trimer
Fitted models: 7cab

Deposition Authors: Zhe L, Cao L
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody.
Lv Z , Deng YQ , Ye Q , Cao L , Sun CY , Fan C , Huang W , Sun S , Sun Y , Zhu L , Chen Q , Wang N , Nie J, Cui Z , Zhu D , Shaw N , Li XF , Li Q, Xie L , Wang Y , Rao Z , Qin CF , Wang X
(2020) Science , 369 , 1505 - 1509
PUBMED: 32703908
DOI: doi:10.1126/science.abc5881
ISSN: 1095-9203
ASTM: SCIEAS